L-Asparaginase Bulk

L-Asparaginase is an enzyme-based bulk API with a well-established role in the treatment of Acute Lymphoblastic Leukemia (ALL). It works by depleting asparagine an amino acid that leukemic cells cannot produce on their own making it a targeted and effective component of oncology treatment protocols.

Manufactured under WHO-GMP conditions and compliant with ICH quality guidelines, this bulk API is produced through a validated fermentation and purification process. Each batch is rigorously tested to ensure consistent potency, ultra-low endotoxin levels and full documentation readiness for global regulatory submissions.